drugset / Trial / NCT00165711

The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.

NCT00165711

Phase 4 Completed Eisai Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Patients who fit the inclusion criteria are admitted into the study. They are given 3 IV injection of MBL in the first week and one tablet three times a day for 16 weeks.

Timeline

Start
2003-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject methylcobalamin Small molecule Intravenous